Why it earned this rating
Our assessment
SecureFore II 5-Year through Wells Fargo earns a Good Option rating for delivering a competitive guaranteed rate — 4.90% to 5.10% depending on premium band — in a clean, no-fee structure backed by an A-rated carrier. The broader state footprint distinguishes it from the original SecureFore Wells Fargo line, and the Chronic and Critical Illness Waiver is a genuine value-add for buyers in the issue-age window where it applies. The channel restriction still caps the rating: this product does not exist if you are outside the Wells Fargo distribution system, and the MVA adds exit risk that a straightforward locked-rate product ideally would not carry.
The short version
This is a 5-year guaranteed-rate annuity sold exclusively through Wells Fargo advisors. You deposit a lump sum, earn a declared interest rate for the full five-year term, and exit at maturity without penalty. The case for choosing it over a 5-year CD comes down to tax-deferred compounding, a death benefit that passes full account value without surrender charges, and a set of health-event waivers — including a Chronic and Critical Illness Waiver not always seen on MYGA products — all at no contract fee. The case against it is mostly a matter of access and MVA exposure: if you are not in the Wells Fargo system or if you are comparing this head-to-head with MVA-free alternatives in the open market, the math is less clearly in its favor.
Key facts
The full review
Is Forethought SecureFore II 5-Year (Wells Fargo) a Good Annuity?
It depends on access and context. For a Wells Fargo client in an approved state with genuine 5-year money and no need for equity-linked growth, this is a solid, low-complexity choice. The rate range in the brochure — 4.90% for most buyers, 5.10% at $100,000 or more — is competitive for a 5-year fixed product, the feature set is clean, and the carrier is well-rated. The product is less compelling if you are comparing it against open-market MYGAs with no MVA exposure, or if you have any realistic chance of needing more than the free-withdrawal amount before year five.
Why Someone Would Buy This Annuity
The primary reason is a guaranteed rate locked in for five years with no annual reset uncertainty. A buyer comparing this to a 5-year CD gets tax-deferred compounding, a full account-value death benefit, and health-event waivers — features a CD does not offer. The five-year term also reduces reinvestment risk compared to shorter instruments: you know what you are earning through maturity. For pre-retirees with a defined block of money they will not need for five years, committing it to a fixed rate while preserving tax deferral is a reasonable allocation. The Chronic and Critical Illness Waiver adds meaningful practical value for buyers who qualify — it waives surrender charges and the MVA on withdrawals after certification of a qualifying illness, and it applies without an added fee.
Who This Annuity Is Best For
I think SecureFore II 5-Year (Wells Fargo) is best for a pre-retiree or early retiree in their mid-50s through mid-70s who is already working with a Wells Fargo advisor, has idle money they will not need for five years, and values certainty over upside potential. Both qualified and non-qualified contracts are available; non-qualified holders get the more meaningful tax-deferral benefit. Buyers aged 65 or under at issue also benefit from the Chronic and Critical Illness Waiver, which strengthens the case for this product over comparable options that lack that waiver. It is not a good fit for anyone who might need access to more than 10% of the account value before maturity, for buyers primarily shopping for income guarantees, or for anyone outside the Wells Fargo distribution channel.
What You're Really Buying Here
A multi-year guaranteed annuity is a fixed-rate insurance contract. You deposit a lump sum, the insurer credits a declared rate each year, the money compounds tax-deferred, and at maturity you receive the accumulated value without penalty. There are no indices, no participation rates, no crediting strategies to monitor. The entire product is the rate guarantee plus the insurance wrapper around it. The wrapper adds two things a CD cannot offer: tax deferral on credited interest until you take distributions, and a death benefit that passes full account value to beneficiaries without surrender charges. The health-event waivers are supporting features — meaningful, but secondary to the core locked-rate guarantee.
How the Core Feature Works
At issue, Forethought declares a fixed interest rate that applies for the entire 5-year term. The brochure notes rates of 4.90% for contracts below the Low Band threshold and 5.10% at $100,000 or more. The rate does not reset annually, does not fluctuate with market conditions, and carries no caps, spreads, or participation-rate adjustments. Your account grows at the declared rate each year on the prior balance. On day one of year six, the surrender charge drops to zero and you can access the full value without penalty or MVA. The simplicity is the product — if you are expecting index-linked upside or equity participation, that is a different product category entirely.
Why the Secondary Feature Matters
The Chronic and Critical Illness Waiver is the most meaningful secondary feature on this contract. After the Benefit Eligibility Date, if the insured is diagnosed with a critical illness or certified as chronically ill, surrender charges and the MVA are waived on amounts withdrawn. The waiver is available at no added fee for buyers who are age 65 or under at issue. For a MYGA buyer in this age range, a health event during the 5-year surrender period is not a remote scenario — having a pathway to access funds without penalty in that situation meaningfully changes the worst-case outcome. Buyers who are older than 65 at issue do not qualify for the Chronic and Critical Illness Waiver, though the terminal illness and nursing home waivers remain available to all contract holders regardless of issue age.
Liquidity and Surrender Schedule
You are trading five years of liquidity — above the 10% free-withdrawal amount — for a locked rate. The surrender schedule runs 8%, 8%, 7%, 6%, 5%, then zero, meaning years one and two carry the steepest penalties. Beyond the schedule itself, a Market Value Adjustment applies on amounts subject to surrender charges. The MVA moves with interest rates: in a rising-rate environment it increases your exit cost beyond the stated charge; in a falling-rate environment it can reduce it. This makes early-exit math less predictable than on an MVA-free product, which is a legitimate caution if you have any chance of needing the money early.
The 10% annual free-withdrawal provision covers most routine access needs. In year one, the free amount is 10% of the Annuity Deposit; from year two forward it is 10% of beginning-of-year contract value. Required minimum distributions attributable to the contract are penalty-free, making the product straightforward to hold inside a traditional IRA. The nursing home waiver activates after 90 consecutive days of qualifying confinement following the first contract anniversary; Florida buyers face a 60-day threshold and must also wait until the first anniversary.
| Contract Year | Surrender Charge |
|---|---|
| 1 | 8% |
| 2 | 8% |
| 3 | 7% |
| 4 | 6% |
| 5 | 5% |
| 6 | 0% |
Fees and Tradeoffs
There are no base contract fees and no rider fees on SecureFore II 5-Year (Wells Fargo). No annual administrative charge, no mortality and expense charge, no separately disclosed crediting spread. What the rate sheet shows is what you earn. The implicit cost embedded in any fixed annuity — the spread between the carrier's portfolio yield and the credited rate — is standard and not unique to this product.
The main structural tradeoffs are the MVA exposure, the 8/8 opening surrender schedule, and the channel restriction. The MVA adds unpredictability to early-exit costs that a clean MYGA without one would not carry. The first two years of surrender charges are higher than some 5-year peers, which raises the stakes for any access above the free-withdrawal amount in the early term. And the Wells Fargo channel restriction means you cannot compare rates and terms against open-market MYGAs at face value — the rate sheet you see is for this channel specifically, and open-market alternatives may price differently.
Product snapshot
| Feature | Details |
|---|---|
| Product Type | Fixed Annuity |
| Surrender Period | 5 years |
| Issue Ages | 0-85 (Q/NQ); 0-75 (NQ Stretch) |
| Minimum Premium | $10,000 |
| Crediting Methods | Fixed declared rate |
| Free Withdrawal | 10% of beginning-of-year contract value (10% of Annuity Deposit in first contract year) annually; also IRDs are penalty-free; Any Required Minimum Distribution (RMD) |
| MGSV | 87.5% of premiums at 1% per annum (minimum guarantee) |
| Death Benefit | Full Contract Value without incurring Withdrawal Charges and MVA; beneficiaries may receive lump-sum or stream of payments |
| Income Rider | Not available |
| Premium Bonus | None |
| Availability | Not available in California or New York |
Carrier snapshot
Legal Entity: Forethought Life Insurance Company
Parent: Global Atlantic Financial Group
Final take
SecureFore II 5-Year through Wells Fargo is a clean, no-fee MYGA that does what it should: lock a competitive rate, protect principal, and stay out of the way. The rate range shown in the brochure is solid for a 5-year fixed product, the feature set is uncomplicated, and the Chronic and Critical Illness Waiver adds meaningful protection for eligible buyers that is not standard across this product category. The much broader state availability relative to earlier Wells Fargo-distributed Forethought products also removes a barrier that limited the prior generation.
The material cautions remain the channel restriction and the MVA. If you are in the Wells Fargo system and in an approved state, comparing the current rate against open-market MVA-free alternatives at the same duration is the right first step. If the rate is competitive and you value the illness waiver and the carrier relationship, this is a reasonable choice. If you cannot access it or prefer a product without MVA exposure on early exits, there are solid open-market alternatives at this duration worth examining.
